Literature DB >> 20225888

Possible important pair of acidic residues in vesicular acetylcholine transporter.

Parul Khare1, Ana M Ojeda, Ananda Chandrasekaran, Stanley M Parsons.   

Abstract

Invariant E309 is in contact with critical and invariant D398 in a three-dimensional homology model of vesicular acetylcholine transporter (VAChT, TC 2.A.1.2.13) [Vardy, E., et al. (2004) Protein Sci. 13, 1832-1840]. In the work reported here, E309 and D398 in human VAChT were mutated singly and together to test their functions, assign pK values to them, and determine whether the residues are close to each other in three-dimensional space. Mutants were stably expressed in the PC12(A123.7) cell line, and transport and binding properties were characterized at different pH values using radiolabeled ligands and filtration assays. Contrary to a prior conclusion, the results demonstrate that most D398 mutants do not bind the allosteric inhibitor vesamicol even weakly. Earlier work showed that most D398 mutants do not transport ACh. D398 therefore probably is the residue that must deprotonate with a pK of 6.5 for binding of vesamicol and with a pK of approximately 5.9 for transport of ACh. Because E309Q has no effect on VAChT functions at physiological pH, E309 has no apparent critical role. However, radical mutations in E309 cause decreases in ACh and vesamicol affinities and total loss of ACh transport. Unlike wild-type VAChT, which exhibits a peak of [(3)H]vesamicol binding centered at pH 7.4, mutants E309Q, E309D, E309A, and E309K all exhibit peaks of binding centered at pH >or=9. The combination of high pH and mutated E309 apparently produces a relaxed (in contrast to tense) conformation of VAChT that binds vesamicol exceptionally tightly. No compensatory interactions between E309 and D398 in double mutants were discovered. Proof of a close spatial relationship between E309 and D398 was not found. Nevertheless, the data are more consistent with the homology model than an alternative hydropathy model of VAChT that likely locates E309 far from D398 and the ACh binding site in three-dimensional space. Also, a probable network of interactions involving E309 and an unknown residue having a pK of 10 has been revealed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225888      PMCID: PMC2875949          DOI: 10.1021/bi901953j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli.

Authors:  Yafei Huang; M Joanne Lemieux; Jinmei Song; Manfred Auer; Da-Neng Wang
Journal:  Science       Date:  2003-08-01       Impact factor: 47.728

2.  Structure and mechanism of the lactose permease of Escherichia coli.

Authors:  Jeff Abramson; Irina Smirnova; Vladimir Kasho; Gillian Verner; H Ronald Kaback; So Iwata
Journal:  Science       Date:  2003-08-01       Impact factor: 47.728

3.  Structural conservation in the major facilitator superfamily as revealed by comparative modeling.

Authors:  Eyal Vardy; Isaiah T Arkin; Kay E Gottschalk; H Ronald Kaback; Shimon Schuldiner
Journal:  Protein Sci       Date:  2004-07       Impact factor: 6.725

4.  Purification and characterization of a nonvesicular vesamicol-binding protein from electric organ and demonstration of a related protein in mammalian brain.

Authors:  B W Hicks; G A Rogers; S M Parsons
Journal:  J Neurochem       Date:  1991-08       Impact factor: 5.372

5.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

6.  Mutational analysis of basic residues in the rat vesicular acetylcholine transporter. Identification of a transmembrane ion pair and evidence that histidine is not involved in proton translocation.

Authors:  M H Kim; M Lu; M Kelly; L B Hersh
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

7.  Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol).

Authors:  G A Rogers; S M Parsons; D C Anderson; L M Nilsson; B A Bahr; W D Kornreich; R Kaufman; R S Jacobs; B Kirtman
Journal:  J Med Chem       Date:  1989-06       Impact factor: 7.446

8.  The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter.

Authors:  A Alfonso; K Grundahl; J S Duerr; H P Han; J B Rand
Journal:  Science       Date:  1993-07-30       Impact factor: 47.728

9.  Multiple protonation states of vesicular acetylcholine transporter detected by binding of [3H]vesamicol.

Authors:  Parul Khare; Aubrey R White; Stanley M Parsons
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

10.  Acetylcholine transport and drug inhibition kinetics in Torpedo synaptic vesicles.

Authors:  B A Bahr; S M Parsons
Journal:  J Neurochem       Date:  1986-04       Impact factor: 5.372

View more
  6 in total

1.  Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.

Authors:  Hongjun Jin; Xiang Zhang; Xuyi Yue; Hui Liu; Junfeng Li; Hao Yang; Hubert Flores; Yi Su; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Nucl Med Biol       Date:  2015-11-07       Impact factor: 2.408

2.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Identification of molecular hinge points mediating alternating access in the vesicular monoamine transporter VMAT2.

Authors:  Dana Yaffe; Sebastian Radestock; Yonatan Shuster; Lucy R Forrest; Shimon Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 4.  SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine.

Authors:  Hakeem O Lawal; David E Krantz
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

5.  Identification of a mammalian vesicular polyamine transporter.

Authors:  Miki Hiasa; Takaaki Miyaji; Yuka Haruna; Tomoya Takeuchi; Yuika Harada; Sawako Moriyama; Akitsugu Yamamoto; Hiroshi Omote; Yoshinori Moriyama
Journal:  Sci Rep       Date:  2014-10-30       Impact factor: 4.379

6.  Crystal structures of MdfA complexed with acetylcholine and inhibitor reserpine.

Authors:  Ming Liu; Jie Heng; Yuan Gao; Xianping Wang
Journal:  Biophys Rep       Date:  2016-10-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.